Engaging Ukrainian TF-CBT therapists in a PRACTICE skills course to support their wellbeing.

Pollio E, Deblinger E, Cooper B, Garbade M, Harrison JP, Pfeiffer E

PRACTICE makes progress, a self-care course for mental health professionals in the child trauma field: A preliminary investigation.

Deblinger E, Pollio E, Cooper B, Harrison JP, Steer RA

Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study.

Giordano P, Pollio B, Sottilotta G, Biasoli C, Daniele F, De Cristofaro R, Peyvandi F, Villa MR, Castaman G, IDEAL Study Group

Metagenomics analysis reveals presence of the Merida-like virus in Georgia.

Potter-Birriel JM, Pollio AR, Knott BD, Chunashvili T, Fung CK, Conte MA, Reinbold-Wasson DD, Hang J

Simoctocog alfa (NuwiqÂŽ) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

Mathias M, Abraham A, Belletrutti MJ, Carcao M, Carvalho M, Chambost H, Chan AKC, Dubey L, Ducore J, Gattens M, Gresele P, Gruel Y, Guillet B, JimĂŠnez-Yuste V, Kitanovski L, Klukowska A, Lohade S, Mancuso ME, Oldenburg J, Pollio B, Sigaud M, Vilchevska K, Wu JKM, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ

Transmission of SARS-CoV-2 among recruits in a US Army training environment: a brief report.

Hakre S, Maljkovic-Berry I, Hang J, Conte MA, Pollio AR, Fung CK, Gandhi J, Peel SA, Lidl GM, Huhtanen ME, Hall TL, Modjarrad K, Friberg HL, O'Connell RJ, Scott PT

Gamification of Primary Care in a Baccalaureate Nursing Education Program.

Pollio EW, Patton EM, Nichols LS, Bowers DA

IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy.

Tagliaferri A, Molinari AC, Peyvandi F, Coppola A, Demartis F, Biasoli C, Borchiellini A, Cultrera D, De Cristofaro R, Daniele F, Giordano P, Marchesini E, Margaglione M, Marino R, Pollio B, Radossi P, Santoro C, Santoro RC, Siragusa S, Sottilotta G, Tosetto A, Piscitelli L, Villa MR, Zanon E, Finardi A, Schiavetti I, Vaccari D, Castaman G

Comparison of violence risk screening experiences of emergency department clinicians.

Roaten K, Browne S, Pollio DE, Khan F, North CS

Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians.

Borchiellini A, Castaman G, Feola G, Ferretti A, Giordano P, Luciani M, Malcangi G, Margaglione M, Molinari AC, Pollio B, Rocino A, Santoro C, Schiavulli M, Zanon E

Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency.

Cojutti PG, Zanon E, Pasca S, Pea F, Italian FXIII Study Group

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.

Liesner RJ, Abraham A, Altisent C, Belletrutti MJ, Carcao M, Carvalho M, Chambost H, Chan AKC, Dubey L, Ducore J, Gattens M, Gresele P, Gruel Y, Guillet B, Jimenez-Yuste V, Kitanovski L, Klukowska A, Lohade S, Mancuso ME, Oldenburg J, Pavlova A, Pollio B, Sigaud M, Vdovin V, Vilchevska K, Wu JKM, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ

Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia.

Casini A, von Mackensen S, Santoro C, Djambas Khayat C, Belhani M, Ross C, Dorgalaleh A, Naz A, Ünal E, Abdelwahab M, Lozeron ED, Trillot N, Susen S, Peyvandi F, de Moerloose P, QualyAfib Study Group

Objective and Subjective Perspectives on Implementation of a Violence Risk Screening Program in an Emergency Department.

Roaten K, Browne S, Pollio DE, Khan F, North CS

SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.

Del Borrello G, Giraudo I, Bondone C, Denina M, Garazzino S, Linari C, Mignone F, Pruccoli G, Scolfaro C, Spadea M, Pollio B, Saracco P